APRIL - SANTE PREVOYANCE : revenue, balance sheet and financial ratios

APRIL - SANTE PREVOYANCE is a French company founded 26 years ago, specialized in the sector Activités des agents et courtiers d'assurances. Based in LYON (69006), this company of category ETI shows in 2024 a revenue of 302.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - APRIL - SANTE PREVOYANCE (SIREN 428702419)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 302 419 000 € 293 998 000 € 279 283 000 € 262 094 000 € 254 529 000 € 236 674 000 € 238 029 000 € 209 193 000 € N/C
Net income 67 675 000 € 65 246 000 € 60 800 000 € 50 267 000 € 39 234 000 € 45 025 000 € 46 783 000 € 40 901 000 € 40 726 €
EBITDA 102 817 000 € 93 730 000 € 86 124 000 € 80 418 000 € 80 845 000 € 76 350 000 € 78 174 000 € 66 988 000 € -135 668 €
Net margin 22.4% 22.2% 21.8% 19.2% 15.4% 19.0% 19.7% 19.6% N/C

Revenue and income statement

In 2024, APRIL - SANTE PREVOYANCE achieves revenue of 302.4 M€. Over the period 2017-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +5.4%. Vs 2023: +3%. After deducting consumption (0 €), gross margin stands at 302.4 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 102.8 M€, representing 34.0% of revenue. Positive scissor effect: EBITDA margin improves by +2.1 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 67.7 M€, i.e. 22.4% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

302 419 000 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

302 419 000 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

102 817 000 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

88 269 000 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

67 675 000 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

33.4%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 2%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 32%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 25.5% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

2.46%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

31.583%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

25.496%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.027

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

1.7%

Solvency indicators evolution
APRIL - SANTE PREVOYANCE

Sector positioning

Debt ratio
2.46 2024
2022
2023
2024
Q1: 0.0
Med: 7.62
Q3: 47.38
Good

In 2024, the debt ratio of APRIL - SANTE PREVOYANCE (2.46) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
31.58% 2024
2022
2023
2024
Q1: 13.01%
Med: 47.62%
Q3: 76.27%
Average

In 2024, the financial autonomy of APRIL - SANTE PREVOYANCE (31.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
0.03 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.12 years
Q3: 1.71 years
Good

In 2024, the repayment capacity of APRIL - SANTE PREVOYANCE (0.03) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 144.52. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.0x. Danger: operating income does not cover interest charges, unsustainable situation.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

144.522

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.037

Liquidity indicators evolution
APRIL - SANTE PREVOYANCE

Sector positioning

Liquidity ratio
144.52 2024
2022
2023
2024
Q1: 123.36
Med: 243.1
Q3: 571.4
Average

In 2024, the liquidity ratio of APRIL - SANTE PREVOYANCE (144.52) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
0.04x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.0x
Q3: 2.2x
Good

In 2024, the interest coverage of APRIL - SANTE PREVOYANCE (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 51 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 226 days. Excellent situation: suppliers finance 175 days of the operating cycle (retail model). Overall, WCR represents 235 days of revenue, i.e. 197.0 M€ to permanently finance.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

197 019 930 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

51 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

226 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

235 j

WCR and payment terms evolution
APRIL - SANTE PREVOYANCE

Positioning of APRIL - SANTE PREVOYANCE in its sector

Comparison with sector Activités des agents et courtiers d'assurances

Valuation estimate

Based on 193 transactions of similar company sales (all years), the value of APRIL - SANTE PREVOYANCE is estimated at 178 610 859 € (range 53 816 981€ - 607 831 105€). With an EBITDA of 102 817 000€, the sector multiple of 1.2x is applied. The price/revenue ratio is 0.98x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
193 transactions
53816k€ 178610k€ 607831k€
178 610 859 € Range: 53 816 981€ - 607 831 105€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
102 817 000 € × 1.2x
Estimation 124 475 787 €
32 150 838€ - 635 360 392€
Revenue Multiple 30%
302 419 000 € × 0.98x
Estimation 297 104 951 €
82 852 725€ - 552 563 692€
Net Income Multiple 20%
67 675 000 € × 2.0x
Estimation 136 207 404 €
64 428 724€ - 621 909 008€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 193 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités des agents et courtiers d'assurances)

Compare APRIL - SANTE PREVOYANCE with other companies in the same sector:

Voir toutes les statistiques du secteur Activités des agents et courtiers d'assurances

Frequently asked questions about APRIL - SANTE PREVOYANCE

What is the revenue of APRIL - SANTE PREVOYANCE ?

The revenue of APRIL - SANTE PREVOYANCE in 2024 is 302.4 M€.

Is APRIL - SANTE PREVOYANCE profitable?

Yes, APRIL - SANTE PREVOYANCE generated a net profit of 67.7 M€ in 2024.

Where is the headquarters of APRIL - SANTE PREVOYANCE ?

The headquarters of APRIL - SANTE PREVOYANCE is located in LYON (69006), in the department Rhone.

Where to find the tax return of APRIL - SANTE PREVOYANCE ?

The tax return of APRIL - SANTE PREVOYANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does APRIL - SANTE PREVOYANCE operate?

APRIL - SANTE PREVOYANCE operates in the sector Activités des agents et courtiers d'assurances (NAF code 66.22Z). See the 'Sector positioning' section above to compare the company with its competitors.